Immunomedics, Inc. (IMMU) Given a $9.00 Price Target by Jefferies Group LLC Analysts

Immunomedics, Inc. (IMMU) Given a $9.00 Price Target by Jefferies Group LLC Analysts


The firm presently has a "buy" rating on the biopharmaceutical company's stock. Jefferies Group LLC's price target points to a potential upside of 9.36% from the company's current price.



from Biotech News